ChronoScale Corporation Common Stock (NASDAQ:CHRN) Shares Gap Up – Time to Buy?

ChronoScale Corporation Common Stock (NASDAQ:CHRN) gapped up prior to trading on Monday . The stock had previously closed at $18.74, but opened at $19.46. ChronoScale Corporation Common Stock shares last traded at $17.67, with a volume of 40,726 shares traded.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings upgraded ChronoScale Corporation Common Stock from a “sell (d-)” rating to a “sell (d)” rating in a research note on Monday, August 24th. One investment analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, ChronoScale Corporation Common Stock currently has a consensus rating of “Reduce” and an average price target of $6.00.

ChronoScale Corporation Common Stock Trading Down 2.9%

The company has a debt-to-equity ratio of 0.06, a quick ratio of 0.51 and a current ratio of 0.51. The company has a market capitalization of $2.57 billion, a P/E ratio of -3.28 and a beta of 1.00. The company has a 50-day simple moving average of $21.60 and a 200 day simple moving average of $16.31.

ChronoScale Corporation Common Stock (NASDAQ:CHRN) last announced its earnings results on Wednesday, August 19th. The company reported ($0.12) earnings per share (EPS) for the quarter. The company had revenue of $18.40 million for the quarter. ChronoScale Corporation Common Stock had a negative return on equity of 197.81% and a negative net margin of 135.66%. Sell-side analysts expect that ChronoScale Corporation Common Stock will post -0.1 earnings per share for the current year.

Institutional Investors Weigh In On ChronoScale Corporation Common Stock

Hedge funds have recently made changes to their positions in the stock. Roble Belko & Company Inc grew its position in ChronoScale Corporation Common Stock by 104.5% during the first quarter. Roble Belko & Company Inc now owns 2,338 shares of the company’s stock worth $25,000 after buying an additional 1,195 shares in the last quarter. Virtu Financial LLC bought a new stake in shares of ChronoScale Corporation Common Stock in the 3rd quarter worth approximately $57,000. Shay Capital LLC bought a new stake in shares of ChronoScale Corporation Common Stock in the 3rd quarter worth approximately $67,000. Geode Capital Management LLC grew its holdings in shares of ChronoScale Corporation Common Stock by 68.9% during the 4th quarter. Geode Capital Management LLC now owns 25,212 shares of the company’s stock worth $218,000 after purchasing an additional 10,281 shares in the last quarter. Finally, Citadel Advisors LLC bought a new stake in shares of ChronoScale Corporation Common Stock during the third quarter valued at approximately $198,000. Institutional investors own 6.42% of the company’s stock.

ChronoScale Corporation Common Stock Company Profile

Ekso Bionics Holdings, Inc (NASDAQ:EKSO) is a leading developer of wearable bionic exoskeletons designed to enhance human mobility and strength. Headquartered in Richmond, California, the company was founded in 2005 (originally as Berkeley Bionics) and completed its initial public offering in 2014. Its patented robotic systems support both rehabilitation and industrial applications by providing powered, adjustable assistance for a range of movement tasks.

In the medical sector, Ekso Bionics offers externally worn exoskeletons such as the EksoNR and EksoGT, which assist patients recovering from stroke, spinal cord injury or other neurological conditions.